Thursday, September 15, 2016

Covalent drugs target cancer protein via new linker

Inhibitors block Mcl-1 protein by reversibly binding to lysines instead of cysteines

via Chemical & Engineering News: Biological SCENE http://ift.tt/2crNZUw
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)